Generic Testing Market Report: 2012 Edition

• Publication date: July 2012
• Report size: 45 pages

Genetic testing, which is also known as DNA testing, is the latest innovation in the field of molecular diagnostics. The genetic testing market segment represents the highest growth opportunity compared to other segments within the molecular diagnostics market. The growth of the market is backed by increasing prevalence of genetic diseases, aging population, and rising awareness. Vast application areas including newborn screening, prenatal and pr...

Genetic testing, which is also known as DNA testing, is the latest innovation in the field of molecular diagnostics. The genetic testing market segment represents the highest growth opportunity compared to other segments within the molecular diagnostics market. The growth of the market is backed by increasing prevalence of genetic diseases, aging population, and rising awareness. Vast application areas including newborn screening, prenatal and preimplantation testing is also expected to add to the future growth of the market.

The technological advancements of genetic testing are expected to break new grounds in the field of personalized medicine as genetic testing helps not only in the better diagnosis of genetic diseases but also aids in selecting the best medication depending on the DNA structure of the patient to ensure superior drug response.

Direct to customer (DTC) genetic testing is one of the major trends in the market, which is expected to bring positive changes in the popularity of genetic testing. However, the quality, accuracy, and proper interpretation of test results of DTC genetic testing continue to challenge the future growth of the market. Furthermore, the risk of genetic discrimination and psychological consequences of genetic testing are also expected to hinder the growth of the market in the coming years.

The current report analyzes the genetic testing market. It discusses the drivers and challenges prevailing in the genetic testing market. It presents the competitive conditions prevailing in the market, along with the profiles of major players.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the global genetic testing market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Global In Vitro Diagnostic Industry

1. Genetic Testing: An Introduction

1.1 Types of Genetic Testing
1.2 Pros and Cons of Genetic Testing
1.3 Insurance Coverage of Genetic Testing
1.4 Cost and Time Factor Associated to Genetic Testing
1.5 Procedure of Genetic Testing
1.6 Risks and Limitations of Genetic Testing

2. Global Genetic Testing Market

Market Value
Market Segmentation
Regional Breakdown
Other Market Statistics

2.1 Genetic Testing Market in Europe

Market Overview
Market Segmentation
Growth Opportunity

2.2 Pharmacogenetics Market in the US

3. Key Trends

3.1 Strong Growth Opportunity for Carrier Genetic testing
3.2 Proactive Healthcare through DTC Genetic Testing
3.3 Legislations to Fight Genetic Discrimination in the US

4. Growth Drivers

4.1 Increasing Knowledge about Genetic Testing
4.2 Rising Ageing Population
4.3 Growing Healthcare Expenditure
4.4 Increasing Prevalence of Cancer

5. Significant Developments 25

5.1 Gene Scan of Alzheimer's Families Identifies Four New Suspect Genes
5.2 WARFARIN Study Launched by Iverson Genetic Diagnostics
5.3 Genzyme Introduces New Genetic Test for Lung Cancers
5.4 Clinical Data Launches Genetic Test for HCM

6. Challenges

6.1 Genetic Discrimination
6.2 Psychological Consequences of Genetic Testing
6.3 Quality Concerns Related to Biochemical Genetic Testing

7. Genetic Testing - Competitive Landscape

Competitive Overview
Market Share

8. Company Profile

8.1 Abbott

Business Description
Key Financials
Business Strategies
Business Diversification strategy
R&D Strategy

8.2 Qiagen NV.

Business Description
Key Financials
Business Strategies
Addressing Unmet Market Needs
Sales and Marketing Strategy

8.3 Roche

Business Description
Key Financials
Business Strategies
Delivering Personalized Healthcare
Creating Sustainable Value
Fostering Innovation

8.4 Quest Diagnostics

Business Description
Key Financials
Business Strategies
Continuously Drive Six Sigma Quality
Leveraging Assets & Capabilities

9. Market Outlook

9.1 Market Forecast

9.2 Forecast Methodology

9.2.1 Dependent and Independent Variables
9.2.2 Correlation Analysis
9.2.3 Regression Analysis
?
List of Charts

Classification of Molecular Diagnostics
Global Molecular Diagnostics Market, 2005-2015E
Global Molecular Diagnostic Market by Region, 2010
Global Genetic Testing Market, 2007-2011
Worldwide Number of Diseases with Availability of Genetic Testing, 2005-2011E
Worldwide Gene Therapy Clinical Trials by Disease, 2011
Worldwide Gene Therapy Clinical Trials by Gene, 2011
Gene Therapy Clinical Trials by Country, 2011
Gene Therapy Clinical Trials by Phase, 2011
Worldwide Market for Potential Cancer Clinical Trials, 2012E-2015E
Global DNA and Gene Chip Market, 2010A-2015E
Global DNA Sequencing Market, 2014E
Global Projected Addressable Market for Genomes, 2011E-2015E
European Genetic Testing Market by Segments, 2011
Growth Opportunity of European Genetic Testing Market, 2011-2015E
Projected Number of Pharmacogenetic Tests in the US, 2003-2013E
Growth of Global Aging Population, 2005-2012E
Global Healthcare Spending, 2005-2015E
New Cases of Cancer Worldwide, 2005-2010
Market Share of Major Players in the Global Molecular Diagnostics Market, 2010
Global Life Science Industry, 2011E
Market Share of Major Players in the Gene Sequencing Market, 2011
Market Share of Major Players in the Microarray Market, 2010
Share of Sales by Reportable Segments, 2011
Net Sales and Net Income of Abbott, 2007-2011
Share of Net Sales by Geographic Segments, 2011
Net Sales and Net Income of Qiagen, 2007-2011
Share of Sales by Segments, 2011
Total Sales of Roche, 2008-2011
Quest Diagnostic’s Revenues by Business Segments, 2011
Quest Diagnostic’s Revenues and Net Income, 2006-2011
Figure 9.1: worldwide Genetic Testing Market, 2011A-2015E

List of Tables

Dependent & Independent Variables, 2007–2011
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output